{"prompt": "['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix B: The Dermatology Life Quality Index (DLQI)', 'The aim of this questionnaire is to measure how much your skin problem has affected your life OVER THE', 'LAST WEEK. Please check one box for each question.', '1.', 'Over the last week, how itchy, sore, painful or stinging has', '- Very much_Alot -', 'your skin been?', 'A little Not at all', '-', '-', '2.', 'Over the last week, how embarrassed or self conscious have', '- Very much A lot', '-', 'you been because of your skin?', 'A little Not at all', '-', '-', '3.', 'Over the last week, how much has your skin interfered with', '- Very much - A lot', 'you going shopping or looking after your home or garden?', 'A little Not at all', 'Not relevant', '-', '-', '4.', 'Over the last week, how much has your skin influenced the', 'Very much A lot', '-', '-', 'clothes you wear?', 'A little Not at all', 'Not relevant', '-', '-', '5.', 'Over the last week, how much has your skin affected any', 'Very much A lot', '-', '-', 'social or leisure activities?', 'A little Not at all', 'Not relevant', '-', '-', '6.', 'Over the last week, how much has your skin made it difficult', 'Very much A lot', '-', '-', 'for you to do any sport?', 'A little Not at all', 'Not relevant', '-', '-', '7.', 'Over the last week, has your skin prevented you from working', 'Yes No', 'Not relevant', '-', '-', '-', 'or studying?', 'If \"No\", over the last week how much has your skin been a', 'A lot - A little', '-', 'problem at work or studying?', 'Not at all', '-', 'Confidential and Proprietary', '75', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix B: The Dermatology Life Quality Index (DLQI) (Continued)', 'Please check one box for each question.', '8.', 'Over the last week, how much has your skin created problems', 'Very much A lot', '-', '-', 'with your partner or any of your close friends or relatives?', 'A little Not at all', 'Not relevant', '-', '-', '-', '9.', 'Over the last week, how much has your skin caused any', 'Very much A lot', '-', '-', 'sexual difficulties?', 'A little Not at all', 'Not relevant', '-', '-', '-', 'Over the last week, how much of a problem has the', '10.', 'Very much A lot', 'treatment for your skin been, for example, by making your', '-', '-', 'A little Not at all', 'Not relevant', 'home messy, or by taking up time?', '-', '-', '-', 'Source: Finlay, 1994.', 'Confidential and Proprietary', '76', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix C: Static Physicians Global Assessment (sPGA) Of Visible', 'Locations', 'The sPGA is the assessment by the Investigator of the overall disease severity at the time of', 'evaluation. In this study, sPGA is used to evaluate psoriasis only in visible locations, defined as', 'dorsal hand, face, neck and hairline.', 'Score', 'Category', 'Description', 'Plaque elevation = 0 (no elevation over normal skin)', '0', 'Clear', 'Scaling = 0 (no evidence of scaling)', 'Erythema = 0 (except for residual hyperpigmentation/', 'hypopigmentation)', 'Plaque elevation = (possible but difficult to ascertain whether', 'there is a slight elevation above normal skin)', '1', 'Almost Clear', 'Scaling = + (surface dryness with some desquamation)', 'Erythema = + (faint, diffuse pink or slight red coloration)', 'Plaque elevation = slight (slight but definite elevation, typically', 'edges are indistinct or sloped)', '2', 'Mild', 'Scaling = fine (fine scale partially or mostly covering lesions)', 'Erythema = mild (light red coloration)', 'Plaque elevation = marked (marked definite elevation with rough', 'or sloped edges)', '3', 'Moderate', 'Scaling = coarser (coarser scale covering most or all of the', 'lesions)', 'Erythema = moderate (definite red coloration)', 'Plaque elevation = marked (marked elevation typically with hard', 'or sharp edges)', '4', 'Severe', 'Scaling = coarser (coarse, non tenacious scale predominates', 'covering most or all of the lesions)', 'Erythema = severe (very bright red coloration)', 'Source: Walsh, 2013.', 'Confidential and Proprietary', '77', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']\n\n###\n\n", "completion": "END"}